Vimarsana
Biggest News Aggregation in the World

Page 43 - Main Board News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Main Board. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Main Board Today - Breaking & Trending Today

Balancing Asean's energy future - Vimarsana News

Balancing Asean's energy future

Navigating collaborative strategies for energy security in the region.

Akeso Published Results from CD47 Antibody Ligufalimab in Combination with Azacitidine for Newly Diagnosed Higher-Risk Myelodysplastic Syndrome and Treatment-naïve Acute Myeloid Leukemia at ASH 2023 - Vimarsana News

Akeso Published Results from CD47 Antibody Ligufalimab in Combination with Azacitidine for Newly Diagnosed Higher-Risk Myelodysplastic Syndrome and Treatment-naïve Acute Myeloid Leukemia at ASH 2023

/PRNewswire/ -- Akeso published two phase Ib clinical results of its innovative CD47 monoclonal antibody ligufalimab (AK117) in combination with azacitidine in...

CNY Gains Versus US Dollar, Week In Review - Vimarsana News

CNY Gains Versus US Dollar, Week In Review

Overnight, we saw Quad Witching (stock and index futures and options expiring) and FTSE Russell and S&P Dow Jones index rebalances raise volumes

Source: forbes.com
Niro Cooke, Dilush Perera join Ambeon Capital Board - Vimarsana News

Niro Cooke, Dilush Perera join Ambeon Capital Board

Latest news, analysis and opinions from the Daily FT, Sri Lanka's only national business newspaper. ..

Source: ft.lk
Majestic Announces Details of Proposed Listing on HKEX For IPO of Subsidiary Persistence Resources - Vimarsana News

Majestic Announces Details of Proposed Listing on HKEX For IPO of Subsidiary Persistence Resources

, - 14, 2023 - Majestic Gold Corp. is pleased to announce that Majestic's 94% owned subsidiary, Persistence Resources Group Ltd. , has issued its prospectus in respect of its listing of shares in the capital of Persistence on the Main Board of The... - Veroeffentlicht am 14.12.2023